|
|
N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺 |
| CAS No.: |
477600-73-0 |
| 分子式： |
C20H25N5 |
| 分子量： |
335.21 |
| 备注： |
中文名称N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺中文同义词N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺N-METHYL-N-[(3R,4R)-4-METHYL-1-(PHENYLMETHYL)-3-PIPERIDINYL]-7H-PYRROLO[2,3-D]PYRIMIDIN-4-AMINE;托法杂质M-RR;(3R,4R)-(1-苄基-4-甲基-哌啶-3-基)-甲基-(7H-吡咯并[2,3-D]嘧啶-4-基)-胺;托伐替尼杂质D;N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺;N-((3R,4R)-1-苄基-4-甲基哌啶-3-基)-N-甲基-7H-吡咯[2,3-D]嘧啶-4-胺;托法替尼杂质1;N-((3R,4R)-1-苄基-4-甲基哌啶-3-基)-N-甲基-7H-吡咯并[2,3-D]嘧啶-4-胺英文名称N-((3R,4R)-1-benzyl-4-methylpiperidin-3-yl)-N-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-amine英文同义词7H-Pyrrolo[2,3-d]pyriMidin-4-aMine,N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-;1H-Pyrrolo[2,3-d]pyriMidin-4-aMine,N-Methyl-N-[(3R,4R)-4-Methyl-1-(phenylMethyl)-3-piperidinyl]-;N-Methyl-N-[(3R,4R)-Chemicalbook4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;TasocitinibIntermediate;-1-Benzyl-4-methylpiperidin-3-yl);N-((3R,4R);N-((3R,4R)-1-BENZYL-4-METHYLPIPERIDIN-3-YL)-N-METHYL-7H-PYRROLO[2,3-D]PYRIMIDIN-;Tofacitinibimpurity6/N-Methyl-N-[(3R,4R)-4-methyl-1-(phenylmethyl)-3-piperidinyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amineCAS号477600-73-0分子式C20H25N5分子量335.45EINECS号相关类别托法替尼中间体;托法替尼intB4;托法替尼杂质;对照品-杂质对照品;标准品;杂质对照品;化学中间体;APIMol文件477600-73-0.mol结构式N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺性质熔点67-69℃密度1.205±0.06g/cm3(Predicted)储存条件underinertgas(nitrogenorArgon)at2–8°C酸度系数(pKa)13.36±0.50(Predicted)N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺用途与合成方法用途N-甲基-N-((3R,4R)-4-甲基-1-苄基-3-哌啶基)-7H-吡咯并[2,3-D]嘧啶-4-胺属于杂环衍生物，可用作医药中间体。 |
| 结构式： |
 |
 |
|
声明：以上信息未经本网证实,仅供参考,华夏化工网不承担任何风险责任. |
|
